Healthcare startups are betting that AI can help them do more with less — including in caring for patients.

Figma aims for a valuation up to $16.4 billion in its NYSE IPO, looking to raise $1.03 billion by selling shares at $25-$28 ...

Heartflow's latest IPO filing reveals a significant increase in quarterly losses to $32.3 million while revenue surged to $37.2 million, signaling both challenges and opportunities in the recovering U ...

Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

Figma announced Monday it is kicking off its IPO roadshow. The company plans to offer more than 36 million shares of class A ...

Tax software company Avalara, which went private in 2022, disclosed on Monday it had confidentially filed for a U.S. initial ...

Now, the unprofitable PomDoctor Ltd. is hoping to join their ranks as China's newest publicly traded online medical services ...

Figma founder CEO Dylan Field has disclosed that he plans to sell 2.35 million shares. At the midrange he’ll be cashing out ...

HeartFlow plans a $100M IPO to fund R&D and new products despite financial risks. Read about its prospects, challenges, and ...

The company’s custom implants compete with devices from Medtronic, Johnson & Johnson and Globus Medical.

Heartflow Inc. continued the steady rhythm of med-tech companies filing to go public, with an S-1 submitted to the U.S. SEC ...